Literature DB >> 16499252

Cost determinants of tuberculosis management in a low-prevalence country.

M Bocchino1, S Greco, Y Rosati, G Mattioli, A Marruchella, P De Mori, C Bibbolino, E Girardi, S Squarcione, C Saltini.   

Abstract

SETTING: Division of respiratory medicine in a specialised infectious disease hospital in Rome, Italy.
OBJECTIVE: Retrospective evaluation of tuberculosis (TB) care associated costs in an integrated in- and out-patient management programme.
DESIGN: Review of the medical records of 92 human immunodeficiency virus negative TB cases admitted between September 2000 and May 2003.
RESULTS: Length of in-hospital stay (45 +/- 35 days) was the major cost determinant, as hospitalisation accounted for almost 80% of the total costs of the case, with fixed bed-per-day charges amounting to 76% of hospital costs. Factors associated with higher costs were chest X-ray score, fever, sputum bacterial load and multidrug resistance (P < 0.05). Cure/treatment completion was achieved in 82% of patients entering the out-patient programme (63% of all cases). Homelessness, age and comorbidities were associated with unfavourable outcomes.
CONCLUSIONS: A closely followed hospital-centred protocol carried out in a high-resource setting may produce acceptable cure/completion treatment rates. As a too high fraction of resources invested in TB control goes toward hospital costs, out-patient treatment strategies should be implemented.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16499252

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  5 in total

1.  Trends in duration of hospitalization for patients with tuberculosis in Montreal, Canada from 1993 to 2007.

Authors:  Kianoush Dehghani; Robert Allard; Jean Gratton; Louise Marcotte; Paul Rivest
Journal:  Can J Public Health       Date:  2011 Mar-Apr

Review 2.  Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.

Authors:  Yoko V Laurence; Ulla K Griffiths; Anna Vassall
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

3.  Predictors of hospitalization of tuberculosis patients in Montreal, Canada: a retrospective cohort study.

Authors:  Lisa A Ronald; J Mark FitzGerald; Andrea Benedetti; Jean-François Boivin; Kevin Schwartzman; Gillian Bartlett-Esquilant; Dick Menzies
Journal:  BMC Infect Dis       Date:  2016-11-15       Impact factor: 3.090

4.  Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy.

Authors:  Luigi R Codecasa; Mondher Toumi; Anna D'Ausilio; Andrea Aiello; Francesco Damele; Roberta Termini; Alessia Uglietti; Robert Hettle; Giorgio Graziano; Saverio De Lorenzo
Journal:  J Mark Access Health Policy       Date:  2017-02-17

Review 5.  A systematic review of economic evaluations of interventions to tackle tuberculosis in homeless people.

Authors:  Everton Nunes Silva; Ana Carolina Esteves da Silva Pereira; Wildo Navegantes de Araújo; Flávia Tavares Silva Elias
Journal:  Rev Panam Salud Publica       Date:  2018-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.